The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker

Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010

(2011) MARIEKE H. OTTEN et al.   JOURNAL OF RHEUMATOLOGY

Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis

(2011) Ali Vasheghani-Farahani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability

(2010) Birgit C. Donner et al.   BASIC RESEARCH IN CARDIOLOGY

Lymphocyte activation in type 1 diabetes mellitus: The increased significance of Kv1.3 potassium channels

(2010) Gergely Toldi et al.   IMMUNOLOGY LETTERS

Drug-Induced QT-Interval Prolongation: Considerations for Clinicians

(2010) Edward C Li et al.   PHARMACOTHERAPY

Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongation

(2010) Alan Y. Chiang et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Inhibition of Kv1.3 potassium current by phosphoinositides and stromal-derived factor-1α in Jurkat T cells

(2009) Yuichiro Matsushita et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

(2009) Srikant Rangaraju et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The functional network of ion channels in T lymphocytes

(2009) Michael D. Cahalan et al.   IMMUNOLOGICAL REVIEWS

Ion channels in T lymphocytes: An update on facts, mechanisms and therapeutic targeting in autoimmune diseases

(2009) Zoltan Varga et al.   IMMUNOLOGY LETTERS

Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes

(2009) M. W. Pennington et al.   MOLECULAR PHARMACOLOGY

Voltage-gated potassium channels as therapeutic targets

(2009) Heike Wulff et al.   NATURE REVIEWS DRUG DISCOVERY

Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus

(2008) C. Poulopoulou et al.   ARTHRITIS AND RHEUMATISM

4-Phenoxybutoxy-substituted heterocycles – A structure–activity relationship study of blockers of the lymphocyte potassium channel Kv1.3

(2008) Silke B. Bodendiek et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus

(2008) Najet Srairi-Abid et al.   FEBS Journal

Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2008) D. S. Goodin et al.   NEUROLOGY

Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes

(2008) Yunzhao R. Ren et al.   PLoS One